Wealth Effects LLC Dynavax Technologies Corp Transaction History

Wealth Effects LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$9.44 - $11.88 $4,720 - $5,940	-500 Reduced 1.8%	27,250 $267,000
Q4 2022 Feb 02, 2023	SELL	$10.27 - $13.29 $179,725 - $232,574	-17,500 Reduced 38.67%	27,750 $295,000
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $9,930 - $17,440	-1,000 Reduced 2.16%	45,250 $472,000
Q2 2022 Aug 03, 2022	BUY	$7.45 - $12.83 $139,687 - $240,562	18,750 Added 68.18%	46,250 $582,000
Q4 2021 Feb 09, 2022	BUY	$13.17 - $20.94 $362,175 - $575,850	27,500 New	27,500 $387,000

257

132M

371K

99.2K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.44B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Effects LLC with notifications on news.